Investor List:

Top Drug Delivery Series B Investors in San Francisco Bay Area (8)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond Ventures·Senior Associate
Sweet spot: $10
Range: $1 - $40
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in Chemicals (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Chemicals (Seed), Investors in AgTech (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Chemicals (Series A), Investors in AgTech (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series B), Investors in Chemicals (Series B), Investors in Chemicals (Series B), Investors in Drug Delivery (Series B), Investors in AgTech (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in Diagnostics (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Steven Berger, Managing Director at Asahi Kasei Corporate Venture Capital
Steven Berger
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts, Investors in Berkeley (CA)
Investors in Drug Delivery (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Impact (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Digital Health (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in IoT (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Impact (Pre-seed), Investors in AgTech (Pre-seed), Investors in IoT (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in ConstructionTech (Seed), Investors in AutoTech (Seed), Investors in AgTech (Seed), Investors in Food and Beverage (Seed), Investors in Impact (Seed), Investors in AutoTech (Seed), Investors in EnergyTech (Seed), Investors in ConstructionTech (Seed), Investors in IoT (Seed), Investors in Digital Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in EnergyTech (Seed), Investors in Impact (Seed), Investors in IoT (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Digital Health (Seed), Investors in Drug Delivery (Series A), Investors in ConstructionTech (Series A), Investors in Drug Delivery (Series A), Investors in AutoTech (Series A), Investors in Food and Beverage (Series A), Investors in AutoTech (Series A), Investors in Impact (Series A), Investors in AgTech (Series A), Investors in ConstructionTech (Series A), Investors in EnergyTech (Series A), Investors in IoT (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series A), Investors in EnergyTech (Series A), Investors in Food and Beverage (Series A), Investors in Digital Health (Series A), Investors in AgTech (Series A), Investors in Digital Health (Series A), Investors in IoT (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in AutoTech (Series B), Investors in ConstructionTech (Series B), Investors in Food and Beverage (Series B), Investors in AgTech (Series B), Investors in Impact (Series B), Investors in AutoTech (Series B), Investors in EnergyTech (Series B), Investors in ConstructionTech (Series B), Investors in IoT (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Digital Health (Series B), Investors in Impact (Series B), Investors in AgTech (Series B), Investors in Food and Beverage (Series B), Investors in EnergyTech (Series B), Investors in IoT (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Digital Health (Series B), Investors in San Francisco Bay Area (Other Lists)
Photo of Amad Elia, Venture Partner at Ganas Ventures
Amad Elia
Ganas Ventures·Venture Partner
Sweet spot: $50K
Range: $50K - $100K
Investors in Chicago (IL), Investors in Ann Arbor (MI), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Drug Delivery (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in E-commerce (Pre-seed), Investors in E-commerce (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in AI (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in BioTech (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in E-commerce (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in E-commerce (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Seed), Investors in AR/VR (Seed), Investors in Gaming/eSports (Seed), Investors in AR/VR (Seed), Investors in Drug Delivery (Seed), Investors in Gaming/eSports (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Drug Delivery (Seed), Investors in E-commerce (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in E-commerce (Seed), Investors in Generative Tech/AI (Seed), Investors in AI (Seed), Investors in Gaming/eSports (Seed), Investors in AR/VR (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in E-commerce (Seed), Investors in AR/VR (Seed), Investors in Digital Health (Seed), Investors in Gaming/eSports (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in E-commerce (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Drug Delivery (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in AR/VR (Series A), Investors in Drug Delivery (Series A), Investors in AR/VR (Series A), Investors in Drug Delivery (Series A), Investors in Gaming/eSports (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Gaming/eSports (Series A), Investors in E-commerce (Series A), Investors in Drug Delivery (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in E-commerce (Series A), Investors in Generative Tech/AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in AR/VR (Series A), Investors in AI (Series A), Investors in Gaming/eSports (Series A), Investors in Generative Tech/AI (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in AR/VR (Series A), Investors in E-commerce (Series A), Investors in Digital Health (Series A), Investors in Gaming/eSports (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Series B), Investors in Gaming/eSports (Series B), Investors in Generative Tech/AI (Series B), Investors in AR/VR (Series B), Investors in AR/VR (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Gaming/eSports (Series B), Investors in E-commerce (Series B), Investors in Drug Delivery (Series B), Investors in E-commerce (Series B), Investors in Generative Tech/AI (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in Health & Hospital Services (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Gaming/eSports (Series B), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Health & Hospital Services (Series B), Investors in AR/VR (Series B), Investors in BioTech (Series B), Investors in E-commerce (Series B), Investors in Digital Health (Series B), Investors in Gaming/eSports (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in E-commerce (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists), Investors in Boston / New England (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Investors who invested in female founders (Other Lists)
Photo of Mike Kramer, Venture Partner at Vensana Capital
Mike Kramer
Vensana Capital·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $40.0M
Investors in Santa Rosa (CA)
Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in San Francisco Bay Area (Other Lists)
Photo of Dave Messina, Partner at Pioneer Fund
Dave Messina
Pioneer Fund·Partner
Sweet spot: $125K
Range: $50K - $200K
Investors in San Francisco (CA)
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Seed), Investors in DeepTech (Seed), Investors in Health & Hospital Services (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in DeepTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in DeepTech (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in Investors who were founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Alex Efron, Associate at Telegraph Hill Partners
Alex Efron
Sweet spot: $15.0M
Range: $7.0M - $50.0M
Investors in San Francisco (CA)
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Material Science (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Space (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Drug Delivery (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Seed), Investors in DeepTech (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in Diagnostics (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Generative Tech/AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Series A), Investors in DeepTech (Series A), Investors in Material Science (Series A), Investors in Generative Tech/AI (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Material Science (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Generative Tech/AI (Series A), Investors in Diagnostics (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Space (Series A), Investors in BioTech (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Therapeutics (Series B), Investors in Drug Delivery (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in DeepTech (Series B), Investors in Space (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in Space (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in DeepTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Generative Tech/AI (Series B), Investors in Diagnostics (Series B), Investors in AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in British Columbia (Other Lists), Investors in Seattle / Portland (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Marguerite Davis, Foresite Capital
Marguerite Davis
Sweet spot: $38.5M
Range: $2.0M - $75.0M
Investors in SF Bay Area (CA)
Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series A), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in San Francisco Bay Area (Other Lists)
Get new data & insights delivered to your inbox